137 related articles for article (PubMed ID: 27566485)
1. Oral immunisation of mice with transgenic rice calli expressing cholera toxin B subunit fused to consensus dengue cEDIII antigen induces antibodies to all four dengue serotypes.
Kim MY; Kim BY; Oh SM; Reljic R; Jang YS; Yang MS
Plant Mol Biol; 2016 Oct; 92(3):347-56. PubMed ID: 27566485
[TBL] [Abstract][Full Text] [Related]
2. Expression and assembly of cholera toxin B subunit and domain III of dengue virus 2 envelope fusion protein in transgenic potatoes.
Kim MY; Li JY; Tien NQ; Yang MS
Protein Expr Purif; 2017 Nov; 139():57-62. PubMed ID: 27335159
[TBL] [Abstract][Full Text] [Related]
3. Expression and active testing of VP7 from GCRV (Grass carp reovirus) fused with cholera toxin B subunit in rice calli.
Zhang Q; Xu B; Pan J; Liu D; Lv R; Yan D
Protein Expr Purif; 2019 Jun; 158():1-8. PubMed ID: 30753891
[TBL] [Abstract][Full Text] [Related]
4. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Huang HJ; Yang M; Chen HW; Wang S; Chang CP; Ho TS; Kao YS; Tien SM; Lin HH; Chang PC; Lai YC; Hsiao YP; Liu YL; Chao CH; Anderson R; Yeh TM; Lin YS; Wan SW
Vaccine; 2022 Apr; 40(15):2299-2310. PubMed ID: 35287985
[TBL] [Abstract][Full Text] [Related]
5. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.
Bal J; Luong NN; Park J; Song KD; Jang YS; Kim DH
Microb Cell Fact; 2018 Feb; 17(1):24. PubMed ID: 29452594
[TBL] [Abstract][Full Text] [Related]
7. Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
Yuki Y; Mejima M; Kurokawa S; Hiroiwa T; Takahashi Y; Tokuhara D; Nochi T; Katakai Y; Kuroda M; Takeyama N; Kashima K; Abe M; Chen Y; Nakanishi U; Masumura T; Takeuchi Y; Kozuka-Hata H; Shibata H; Oyama M; Tanaka K; Kiyono H
Plant Biotechnol J; 2013 Sep; 11(7):799-808. PubMed ID: 23601492
[TBL] [Abstract][Full Text] [Related]
8. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
Khanam S; Pilankatta R; Khanna N; Swaminathan S
Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
[TBL] [Abstract][Full Text] [Related]
9. Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity.
Park J; Lee HY; Khai LT; Thuy NTT; Mai LQ; Jang YS
Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32075300
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
Matoba N; Kajiura H; Cherni I; Doran JD; Bomsel M; Fujiyama K; Mor TS
Plant Biotechnol J; 2009 Feb; 7(2):129-45. PubMed ID: 19037902
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
12. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization.
Kim SH; Yang IY; Jang SH; Kim J; Truong TT; Van Pham T; Truong NU; Lee KY; Jang YS
Microbes Infect; 2013 Nov; 15(13):895-902. PubMed ID: 23892099
[TBL] [Abstract][Full Text] [Related]
13. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
14. N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.
Hamorsky KT; Kouokam JC; Jurkiewicz JM; Nelson B; Moore LJ; Husk AS; Kajiura H; Fujiyama K; Matoba N
Sci Rep; 2015 Jan; 5():8003. PubMed ID: 25614217
[TBL] [Abstract][Full Text] [Related]
15. Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes.
Poggianella M; Slon Campos JL; Chan KR; Tan HC; Bestagno M; Ooi EE; Burrone OR
PLoS Negl Trop Dis; 2015; 9(7):e0003947. PubMed ID: 26218926
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli.
Huy NX; Kim SH; Yang MS; Kim TG
Plant Cell Rep; 2012 Oct; 31(10):1933-42. PubMed ID: 22736145
[TBL] [Abstract][Full Text] [Related]
17. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.
Brandler S; Ruffie C; Najburg V; Frenkiel MP; Bedouelle H; Desprès P; Tangy F
Vaccine; 2010 Sep; 28(41):6730-9. PubMed ID: 20688034
[TBL] [Abstract][Full Text] [Related]
18. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
[TBL] [Abstract][Full Text] [Related]
19. Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants.
Kim TG; Kim MY; Yang MS
Protein Expr Purif; 2010 Dec; 74(2):236-41. PubMed ID: 20691270
[TBL] [Abstract][Full Text] [Related]
20. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit.
Matsumoto Y; Suzuki S; Nozoye T; Yamakawa T; Takashima Y; Arakawa T; Tsuji N; Takaiwa F; Hayashi Y
Transgenic Res; 2009 Apr; 18(2):185-92. PubMed ID: 18763047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
